Mapping of the chromosomal amplification 1p21-22 in bladder cancer
详细信息 查看全文
- 作者：Mauro Scaravilli ; Paola Asero ; Teuvo LJ Tammela ; Tapio Visakorpi…
- 关键词：Gene amplification ; Bladder cancer ; DR1 ; aCGH
- 刊名：BMC Research Notes
- 出版年：2014
- 出版时间：December 2014
- 年：2014
- 卷：7
- 期：1
- 全文大小：1,201 KB
- 参考文献：1. Jemal, A, Bray, F, Center, MM, Ferlay, J, Ward, E, Forman, D (2011) Global cancer statistics. CA Cancer J Clin 61: pp. 69-902 CrossRef
2. Lagwinski, N, Thomas, A, Stephenson, AJ, Campbell, S, Hoschar, AP, El-Gabry, E, Dreicer, R, Hansel, DE (2007) Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol 31: pp. 1777-1787 CrossRef
3. H?glund, M (2012) The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles. Urol Oncol 30: pp. 533-540 CrossRef
4. Kallioniemi, A, Kallioniemi, OP, Citro, G, Sauter, G, DeVries, S, Kerschmann, R, Caroll, P, Waldman, F (1995) Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer 12: pp. 213-219 CrossRef
5. Voorter, C, Joos, S, Bringuier, PP, Vallinga, M, Poddighe, P, Schalken, J, du Manoir, S, Ramaekers, F, Lichter, P, Hopman, A (1995) Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 146: pp. 1341-1354
6. Richter, J, Jiang, F, Gorog, JP, Sartorius, G, Egenter, C, Gasser, TC, Moch, H, Mihatsch, MJ, Sauter, G (1997) Marked genetic differences between stage pTa and stage pT1 in papillary bladder cancer detected by comparative genomic hybridization. Cancer Res 57: pp. 2860-2864
7. Hovey, RM, Chu, L, Balazs, M, DeVries, S, Moore, D, Sauter, G, Carroll, PR, Waldman, FM (1998) Genetic alterations in primary bladder cancer and their metastasis. Cancer Res 58: pp. 3555-3560
8. Richter, J, Wagner, U, Schraml, P, Maurer, R, Alund, G, Knonagel, H, Moch, H, Mihatsch, MJ, Gasser, TC, Sauter, G (1999) Chromosomal imbalances are associated with high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 59: pp. 5687-5691
9. Pinkel, D, Segraves, R, Sudar, D, Clark, S, Poole, I, Kowbel, D, Collins, C, Kuo, WL, Chen, C, Zhai, Y, Dairkee, SH, Ljung, BM, Gray, JW, Albertson, DG (1998) High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 20: pp. 207-211 CrossRef
10. Hodgson, G, Hager, JH, Volik, S, Hariono, S, Wernick, M, Moore, D, Nowak, N, Albertson, DG, Pinkel, D, Collins, C, Hanahan, D, Gray, JW (2001) Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 29: pp. 459-464 CrossRef
11. Veltman, JA, Fridlyand, J, Pejavar, S, Olshen, AB, Korkola, JE, DeVries, S, Carroll, P, Kuo, WL, Pinkel, D, Albertson, D, Cordon-Cardo, C, Jain, AN, Waldman, FM (2003) Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: pp. 2872-2880
12. Blaveri, E, Brewer, JL, Roydasgupta, R, Fridlyand, J, DeVries, S, Koppie, T, Pejavar, S, Mehta, K, Carroll, P, Simko, JP, Waldman, FM (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: pp. 7012-7022 CrossRef
13. Hurst, CD, Fiegler, H, Carr, P, Williams, S, Carter, NP, Knowles, MA (2004) High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 23: pp. 2250-2263 CrossRef
14. Habuchi, T, Devlin, J, Elder, PA, Knowles, MA (1995) Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene 11: pp. 1671-1674
15. Kimura, F, Florl, AR, Seifert, HH, Louhelainen, J, Maas, S, Knowles, MA, Schulz, WA (2001) Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Br J Cancer 85: pp. 887-893
16. Aveyard, JS, Knowles, MA (2004) Measurement of relative copy number of CDKN2A/ARF and CDKN2B in bladder cancer by real-time quantitative PCR and multiplex ligation-dependent probe amplification. J Mol Diagn 6: pp. 356-365
文摘
Background The aim of the study was to characterize a recurrent amplification at chromosomal region 1p21-22 in bladder cancer. Methods ArrayCGH (aCGH) was performed to identify DNA copy number variations in 7 clinical samples and 6 bladder cancer cell lines. FISH was used to map the amplicon at 1p21-22 in the cell lines. Gene expression microarrays and qRT-PCR were used to study the expression of putative target genes in the region. Results aCGH identified an amplification at 1p21-22 in 10/13 (77%) samples. The minimal region of the amplification was mapped to a region of about 1?Mb in size, containing a total of 11 known genes. The highest amplification was found in SCaBER squamous cell carcinoma cell line. Four genes, TMED5, DR1, RPL5 and EVI5, showed significant overexpression in the SCaBER cell line compared to all the other samples tested. Oncomine database analysis revealed upregulation of DR1 in superficial and infiltrating bladder cancer samples, compared to normal bladder. Conclusions In conclusions, we have identified and mapped chromosomal amplification at 1p21-22 in bladder cancer as well as studied the expression of the genes in the region. DR1 was found to be significantly overexpressed in the SCaBER, which is a model of squamous cell carcinoma. However, the overexpression was found also in a published clinical sample cohort of superficial and infiltrating bladder cancers. Further studies with more clinical material are needed to investigate the role of the amplification at 1p21-22.